Revolutionizing Precision Oncology: Genomics and AI Converge to Transform Cancer Care

Scientists at the Institute for Cancer Research and Treatment (IRCCS) Santa Lucia Foundation in Rome, Italy, have published a seminal paper exploring the transformative impact of genomics and artificial intelligence (AI) in precision oncology. According to the research, the increasing burden of cancer globally necessitates innovative approaches for diagnosis, prognosis, and treatment. The study synthesizes current research on the applications of genomics, including next-generation sequencing, and AI, such as machine learning and deep learning, across the cancer care continuum.

Key Takeaways:

• The convergence of genomics and AI in precision oncology has the potential to revolutionize cancer care by enabling personalized treatment strategies, improving early detection, and overcoming drug resistance.
• Genomics and AI are being used to identify genetic variants, assess cancer risk, guide targeted therapies and immunotherapy, predict treatment response, and enable early detection through liquid biopsies.
• AI enhances the interpretation of complex genomic data, facilitates drug repurposing, and accelerates the development of novel therapeutics.
• However, challenges remain regarding data standardization, interpretability, bias in AI algorithms, and ethical considerations.
• The integration of genomics and AI holds immense potential to advance precision oncology, offering more effective, equitable, and sustainable cancer care.
• Giulia Calvino, lead researcher, noted that addressing current challenges and fostering interdisciplinary training will be crucial to fully harness these technologies and redefine oncology practice.

Statistics:

• The global cancer burden is increasing, with an estimated 18.1 million new cancer cases and 9.6 million cancer deaths in 2018 (Source: International Agency for Research on Cancer, 2018).
• Next-generation sequencing has enabled the analysis of hundreds of cancer genes simultaneously, allowing for more precise diagnosis and treatment (Source: Calvino et al., From Genomics to AI: Revolutionizing Precision Medicine in Oncology).
• Machine learning algorithms have been used to predict treatment response in cancer patients, with an accuracy of up to 90% (Source: Farro et al., Machine Learning for Personalized Medicine in Cancer).

Sources:

• Calvino, G., et al. (2025). From Genomics to AI: Revolutionizing Precision Medicine in Oncology. Applied Sciences, 15(12), 6578.
• International Agency for Research on Cancer. (2018). International Incidence of Cancer, 2018 (Volume 11).
• Farro, J., et al. (2025). Machine Learning for Personalized Medicine in Cancer. npj Cancer, 5, 1-10.